Advertisement
Home »

Biguanides and DPP-4 Inhibitors for T2DM Show No Differences in Cardiac/Cerebrovascular Events, Diabetic Complications or Death

Aug 17, 2024

ABOUT THE EXPERTS

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


RELEVANT ARTICLES FOR YOU

Advertisement